US HB7658 | 2021-2022 | 117th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on May 3 2022 - 25% progression, died in committee
Action: 2022-05-03 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 3 2022 - 25% progression, died in committee
Action: 2022-05-03 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.
Title
To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.
Sponsors
| Rep. Tom O'Halleran [D-AZ] | Rep. Debbie Lesko [R-AZ] |
History
| Date | Chamber | Action |
|---|---|---|
| 2022-05-03 | House | Referred to the House Committee on Energy and Commerce. |
| 2022-05-03 | House | Introduced in House |
Same As/Similar To
HB7667 (Related) 2022-06-09 - Received in the Senate.
SB4152 (Same As) 2022-05-05 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB4348 (Related) 2022-07-13 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 444.
SB4152 (Same As) 2022-05-05 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB4348 (Related) 2022-07-13 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 444.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/7658/all-info |
| Text | https://www.congress.gov/117/bills/hr7658/BILLS-117hr7658ih.pdf |
